A simple pharmacokinetic model, incorporating linear plasma protein binding, linear tissue binding, and first order elimination of free (unbound) drug, was studied. If Clp is the plasma clearance, Vf is the "true" volume of distribution of free drug, B is the apparent elimination rate constant, ~ is the fraction of the drug which is free in plasma, f is the fraction of the drug which is free in the entire body, kf is the intrinsic elimination rate constant for free drug, and A~B is the initial amount of drug which is bound to tissues, then the model indicates that the following relationships hold: (I) Cl~ = Vf~ kf; (2) ~ = f kf; and Vdex t = (o/f) Vf. Only o, and not f, can be measured experimentally.
A simple pharmacokinetic model, incorporating linear plasma protein binding, linear tissue binding, and first order elimination of free (unbound) drug, was studied. If Clp is the plasma clearance, Vf is the "true" volume of distribution of free drug, B is the apparent elimination rate constant, ~ is the fraction of the drug which is free in plasma, f is the fraction of the drug which is free in the entire body, kf is the intrinsic elimination rate constant for free drug, and A~B is the initial amount of drug which is bound to tissues, then the model indicates that the following relationships hold: (I) Cl~ = Vf~ kf; (2) ~ = f kf; and Vdex t = (o/f) Vf. Only o, and not f, can be measured experimentally.
Dividing Clp by provides an estimate of the intrinsic clearance of free drug, Vfkf. A plot of Vdext versus ~ has an intercept equal to Vf, and the ratio of the slope/intercept is" an estimate of A~/ A~, where A~ is the initial amount of free drug (equalo to Vf times initial concentration of free drug in plasma). Thus, an estimate of A~B may be obtained. Dividing the intrinsic clearance by Vf provides an estimate of kf.
•
• O Thus, theoretlcally, est±mates of Vf, kf, ATB and f may be obtained. The variables are not separated when ~ is plotted versus ~, and curvature of such plots is expected; no useful information is obtained from such plots.
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There has been much discussion in the literature on the effects of plasma protein binding on the distribution, elimination, and activity of drugs (Anton and Solomon, 1973; Benya and Wagner, 1975; Coffey, 1972; Garrett, 1972; Keen, 1972; KrHger-Thiemer, 1966 and 1968; Levy and Yacobi, 1974; Martin, 1965; Wagner, 1971 and 1975) and these citations are not intended to be complete. The review of Keen (1971) not only discussed the mPartly supported by Public Health Service Grant 5-P-II-GM 1559 and partly by Grant IROIAAOO683-possible effects of plasma protein binding, but also discussed the possible effects of tissue binding. He cited data showing that cardiac glycosides which are highly bound to plasma proteins are also highly bound to tissues. A similar situation has been reported for diphenhydramine (Wagner, 1973 and Albert et el., 1975) and for warfarin in the rat (Benya and Wagner, 1975; Yacobi and Levy, 1975) . Several authors (Coffey, 1972; Garrett, 1972; Keen, 1971; Kr~ger-Thiemer, 1966 and 1968; Levy and Yacobi, 1974; Martin, 1965; Yacobi and Levy, 1975) b o t h p l a s m a p r o t e i n b i n d i n g and b i n d i n g to s e v e r a l d i f f e r e n t types of tissues; they a s s u m e d t h a t the r e l a t i o n s h i p for b i n ding to p l a s m a p r o t e i n s c o u l d also be u s e d for t i s s u e binding; e q u a t i o n s used w e r e those of the L a n g m u i r type. H e r m a n n (1975) s h o w e d that the b i n d i n g of o u a b a i n and d i g i t o x i n by h u m a n e r y t h r o c y t e s o b e y e d the L a n g m u i r equation. W h e n the d i s s o c iation c o n s t a n t is m u c h g r e a t e r than the d r u g c o n c e n t r a t i o n , the L a n g m u i r e q u a t i o n c o l l a p s e s to a l i n e a r b i n d i n g e q u a t i o n .
In i n t e r -i n d i v i d u a l c o m p a r i s o n s of a g r o u p of one s p e c i e s of a n i m a l or m a n it w o u l d be a d v a n t a g e o u s if one c o u l d predict, for example, the p l a s m a c l e a r a n c e of a d r u g by m e a s u r e m e n t of the f r a c t i o n of the d r u g w h i c h is free in p l a s m a . The q u e s t i o n a r i s e s as to w h i c h are the app r o p r i a t e p h a r m a c o k i n e t i c p a r a m e t e r s to c o r r e l a t e w i t h this fraction. The purpose of this r e p o r t is to d e t e r m i n e w h i c h r e l a t i o n s h i p or r e l a t i o n s h i p s h a v e a firm f o o t i n g in p h a r m a c o k i n e t i c theory, r a t h e r than the a l t e r n a t i v e a p p r o a c h of just m a k i n g e m p i r i c a l c o r r e l a t i o n s . The p h y s i c a l m o d e l a p p r o a c h also s u g g e s t s w h e n one m i g h t e x p e c t a t r e n d line to be l i n e a r or curved; often, s c a t t e r in data, as a r e s u l t of just b i o l o g i c a l v a r i a t i o n and assay error, d o e s not a l l o w one to a d e q u a t e l y d e t e r m i n e w h e n a t r e n d line s h o u l d be l i n e a r or curved. 
T H E O R E T I C A L Assumptions
Symbolism I. W h e n the dose, D, is g i v e n by b o l u s i n t r a v e n o u s injection, the d r u g i n s t a nAf -a m o u n t (moles) of free d r u g at time t. t a n e o u s l y is p a r t i t i o n e d into three portions, n a m e l y A~B , A~B , and A~. A~ -i n i t i a l a m o u n t (moles) of free drug at time zero. ApB-a m o u n t (moles) of p l a s m a p r o t e i n b o u n d drug at time t. 
A~B-i n i t i a l a m o u n t (moles

A~B-i n i t i a l a m o u n t (moles) of t i s s u e
b o u n d d r u g at time zero. 8 -a p p a r e n t e l i m i n a t i o n rate c o n s t a n t , such that -d in Cp/dt = 8 Clp-p l a s m a c l e a r a n c e ~d e f i n e d by equation 31).
B i n d i n g to b o t h p l a s m a p r o t e i n and t i s s u e is l i n e a r and i n d e p e n d e n t of drug c o n c e n t r a t i o n .
3. The v o l u m e o c c u p i e d by p l a s m a proteins is i g n o r e d and h e n c e ApB = V f C p B and Af = VfCf.
4. The free d r u g is e l i m i n a t e d a c c o r ding to first o r d e r k i n e t i c s w i t h rate c o n s t a n t equal to kf.
5. O n l y free d r u g is a v a i l a b l e for e l i m i n a t i o n . In equation 6, the term containing the integral represents the amount of drug eliminated between time zero and time t'. Differentiation of equation 6 with respect to time yields equation 7.
Eq. (9) Substituting from equations 8 and 9 into equation 7 Thus, according to this simple model, the apparent elimination rate constant, 8, is a product of the intrinsic elimination rate constant for free drug, kf, and the fraction of the total amount of drug in the body which is free, f.
If we define a as the fraction of the drug which is free (unbound) in the volume Vf (and plasma is assumed to be representative of this fluid), then: Hence, the model predicts that the apparent elimination rate constant, ~, obtained from total plasma concentrations is the same as that obtained from free drug concentrations.
The initial condition at time zero for the model is given by equation 27.
÷A B=D Eq (27)
In equation 27, A~, A~B , and A~B are the initial amounts existing as free drug, drug bound to tissues, and drug bound to plasma proteins, respectively, and D is the dose administered. In real life it would take some finite time, even when the values of k I and k 3 are large, to attain this "initial condition", but this lag time, tl, would most probably be small relative to the measured time courses of most drugs. The model assumes such partitioning, as indicated by equation 27, has already occurred at time zero. Hence, in real life the only difference would be that the D in equation 27 would be replaced by A~, the apparent initial amount of drug in the body, such that A~ < D, and t would be replaced by (t -tl).
An Thus, according to the model, the calculated plasma clearance, CID, is the product of the intrinsic clearance of free drug, Vf kf, and the fraction of the drug which is free in plasma, ~. For inter-individual comparisons a plot of Clp v e r s u s ~ should yield a straight line, passing through the origin, with slope equal to Vf kf, providing that the intrinsic clearance of free drug is constant from one individual to the next. Alternatively, and preferred, the plasma clearance of each individual may be divided by the fraction of drug free in plasma for that individual to obatin individual estimates of the intrinsic clearance, then these analyzed statistically to obtain a measure of dispersion.
Vdarea is usually calculated with equation 34. The portion of equation 38 marked off by square brackets can have a value ranging from much less than unity to much greater than unity, depending upon the relative degrees of plasma protein bindbracketed portion will be much larger than unity, and Vdare a >> Vf. If a = 0.5 and (A~B + A~B)/D = 0.5, then the bracketed portion would be equal to unity and Vdarea = Vf. Even for a drug which is both very highly plasma protein bound and tissue bound, Vdare a could be equal to Vf; for example, if ~ = 0.02 and (A~B + A~B)/D = 0.98, then the bracketed portion would be equal to unity. Usually, of course, the bracketed portion would not be equal to unity, hence either Vdare a > Vf or Vdarea < Vf. Thus, the calculated volume of distribution is not equal, usually, to the volume of distribution of free drug.
The Keen (1971) recommended that the volume of distribution be calculated from free drug concentrations, rather than from total drug concentrations. If this is done, then the volume calculated, based on the simple model, is Vf/f. The same result would be obtained by dividing the volumes, Vdext and Vdarea, estimated from total drug concentrations, by ~. It should be noted that such volumes are still d e p e n d e n t upon relative degrees of plasma protein binding and tissue binding, as pointed out by Keen (1971) . The product of the apparent e l i m i n a t i o n rate constant, 8, and such a volume (estimated from free drug concentrations) is, by use of equation 18, equal to the intrinsic clearance of free drug, as indicated by equation 44.
Eq. (44) If there are m u l t i c o m p a r t m e n t a l pharmacokinetics, then the volume calculated from free drug c o n c e n t r a t i o n s should be the m o d i f i e d Vdarea, rather than Vdext , unless, as is sometimes the case, the two volumes are e s s e n t i a l l y identical. (2) A plot of the e x t r a p o l a t e d volume of distribution, Vdext , v e r s u s fraction free in plasma, a, has an intercept equal to Vf and a slope equal to (ATB/Af) Vf, hence the ratio ATB/A f is obtained by dividing the slope by the intercept. Once V~ and ATB/A f are known, then kf, f, and A~B are readily obtained, providing there is not much variation in ATB/A{.
E s t i m a t i o n o f V f a n d A T B / A f -S u b s t i t u t i n g
(3) The apparent eliminatio~ rate constant, B, is e q u i v a l e n t to the product of'the intrinsic elimination rate constant for free drug, kf, and the fraction of the total drug in the body which is free, symbolized by f. It should be noted that B is not equal to ~ kf, unless there is a b s o l u t e l y no tissue binding. When B is plotted v e r s u s a, the variables are not separated, and the plot will have a gentle curvature. If, also, ATB/A f varies appreciably from one individual to the next, then there will be considerable scatter on the 6 v e r s u s ~ plots. These types of plots are n o t recommended. Since the binding of drugs to plasma proteins is extremely rapid (Keen, 1971) and the binding of some drugs to tissues is also extremely rapid (see Wagner, 1973 for d i p h e n h y d r a m i n e in the rat; and Benya and Wagner, 1975 for w a r f a r i n in the rat), one might expect the model to hold f o r l o w d o s e s in some cases. It should be noted that if one derives equations for a similar model, but with several different types of tissues, the same general form for equation 17 is obtained, except that there are additional terms in the d e n o m i n a t o r for each type of tissue (see Wagner, 1971 ).
The equations derived in this article and the conclusions reached differ appreciably from some of those of Keen (1971) , Coffey (1972) , Krfiger-Thiemer (1966 and 1968) , Levy and Yacobi (1974) and Yacobi and Levy (1975) . The reason for the differences is the inclusion of both tissue binding and plasma protein binding in the model and derivations in the present article, whereas previous authors cited were p r i n c i p a l l y concerned only with plasma protein binding. It is hoped that this article will aid in obtaining additional p h a r m a c o k i n e t i c information when a drug is a d m i n i s t e r e d by bolus intravenous injection to either a panel of subjects or patients or to a group of animals of one species. Also, it discloses some possible pitfalls in the analysis of such p h a r m a c o k i n e t i c data.
